Nadine Baudot-Trajtenberg - 17 Sep 2026 Form 4 Insider Report for Cellebrite DI Ltd. (CLBT)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
17 Sep 2026, 08:05:15 UTC
Prior SEC filing
18 Mar 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Nadine Baudot-Trajtenberg

Key filing fact

Nadine Baudot-Trajtenberg filed Form 4 for Cellebrite DI Ltd. (CLBT) on 17 Sep 2026.

Key facts

  • This page summarizes Nadine Baudot-Trajtenberg's Form 4 filing for Cellebrite DI Ltd. (CLBT).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 17 Sep 2026, 08:05.

Change

  • Previous filing in this sequence was filed on 18 Mar 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001970941 Primary reporting owner

Baudot-Trajtenberg Nadine

Relationship
Director
Address
94 SHLOMO SHMELZER ROAD, PETAH TIKVA, ISRAEL
Signature
/s/ Nadine Baudot-Trajtenberg
Signature date
17 Sep 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CLBT transaction

Ordinary shares, par value NIS 0.00001

Award

Transaction value
Shares
+15,190
Change %
+43%
Price
$0.000000*
Shares after
50,744
Date
17 Sep 2026
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents an award of restricted share units ("RSUs") that will vest on September 17, 2027. Each RSU represents a contingent right to receive one Ordinary Share of the Issuer upon settlement.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .